The present invention provides compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. Present compounds are thus useful for the treatment of various cancers.
POHJALA E. K., ACTA CHEM. SCAND., 1980, B 34, NO 2, 79-83
作者:POHJALA E. K.
DOI:——
日期:——
DIHYDROQUINOLINONES
申请人:C4 Therapeutics, Inc.
公开号:EP3679028A1
公开(公告)日:2020-07-15
DIHYDROQUINOLINONES FOR MEDICAL TREATMENT
申请人:C4 Therapeutics, Inc.
公开号:US20200207733A1
公开(公告)日:2020-07-02
The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
Pohjala, E. K., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1980, vol. 34, # 2, p. 79 - 84